Jonca Bull
Jonca works to advance clinical development programs to ensure that new medical therapies are made available to patients in a rapid and cost-efficient manner beginning with early phases of clinical development throughout the product life cycle.
Based in PPD’s Washington, D.C., area office, Jonca joined PPD in 2017 following a career with the U.S. Food and Drug Administration (FDA) and in the pharmaceutical industry. She has significant therapeutic experience in clinical regulatory development consulting for biopharmaceutical products across a range of therapeutic areas with a specific interest in ensuring that clinical trials are patient centric in addressing unmet needs. Prior to joining PPD, Jonca served as assistant commissioner at FDA with a focus on diverse populations and clinical trials; vice president for U.S./North American regulatory policy for Novartis Pharmaceuticals; and director of clinical regulatory policy for Genentech. From 1994 to 2005, Jonca held various senior leadership roles with the FDA across various disease areas and programs. From 1982 to 1994 she cared for patients at a medical/surgical practice in the Washington metro area. She is a diplomat of both the American Board of Ophthalmology and the National Board of Medical Examiners.
Jonca holds an undergraduate degree from Princeton University, a medical degree from Duke University, and she completed residencies in general medicine and ophthalmology at George Washington University Hospital in Washington, D.C., where she also serves as an assistant clinical professor. She is a recipient of a 2017 Year of Women Award in recognition of great accomplishment to the field of ophthalmology by Women in Ophthalmology.